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ABSTRACT 
International Journal of Exercise Science 14(3): 260-273, 2021. The study purpose was to determine the 
relationship of resting heart rate variability (HRV) and testosterone to cortisol (T:C) ratio, along with the diagnostic 
ability of HRV to assess changes in T:C ratio during a 9-week high-intensity functional training intervention. Eight 
recreationally-active men (n = 4, age 24.25 ± 1.75 yrs, height 181.25 ± 3.86 cm, weight 79.68 ± 11.66 kg) and women 
(n = 4, age 26 ± 3.6 yrs, height 164.25 ± 3.3, weight 73.4 ± 8.42) completed daily HRV measurements (HRVdaily) 
using photoplethysmography via a commercially-available smartphone application along with weekly saliva 
samples. Saliva samples were analyzed for concentrations of testosterone (T) and cortisol (C) via enzyme-linked 
immunosorbent assays. Upon study completion 72 data points were available, due to participant compliance and 
inadequate saliva sample, 67 matched pairs of HRV and T:C ratio were analyzed. A statistically significant negative 
relationship (n = 67, r = -.315, p < 0.05) was found between HRVdaily and saliva T:C ratio concentrations within 
aggregate data. Individual participant relationships showed considerable variability (r = - 0.101 – 0.665, p = 0.103 
to 0.829 The model which best explained the data resulted in AIC = 130.247 with factors HRVdaily (β = -0.218, 
95%CI = -0.391, -0.044, t = -2.46, p < 0.05), Sex (β = 0.450, 95%CI = -0.214, 1.114, t = 1.113, p = 0.242), and Group (β = 
-0.394, 95%CI = -1.089, 0.302, t = -1.11, p = 0.311). Diagnostically, HRVdaily demonstrates excellent sensitivity (95%), 
but poor specificity (5%) for detecting meaningful changes in T:C ratio. Assessment of HRVdaily may be a clinically 
valid proxy measure for monitoring hormonal changes throughout a training intervention.  
 





Exercise training represents a significant perturbation to both the human neuroendocrine and 
autonomic nervous systems (ANS) (2, 56). Well-planned exercise training programs attempt to 
balance both acute and chronic training loads (TL) in order to maximize physiological 
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adaptation and attenuate the risk of maladaptation (6, 16, 21). The imposed stresses from 
exercise TL can be viewed on a continuum with fatigue anchoring one end and recovery the 
other (17). As such, poor management of TL due to imbalance between training stresses and 
recovery may increase the risk of injury or lead to a state non-functional overreaching (5, 37). 
Conversely, effective TL management results in the adaptation of various physiological systems 
to a higher fitness level (17, 22). Practitioners have often faced difficulties in maintaining TL 
balance as individual responses to acute and chronic exercise are unique. Thus, the ability to 
monitor TL through objective measures may enhance understanding of individual training 
responses and reduce the risk of maladaptation (16, 21).  
 
Monitoring strategies for quantifying internal TL (i.e., physiological responses to training) 
include blood lactate concentrations, heart-rate based metrics, and hormonal responses (4, 7, 21). 
Exercise-induced hormonal responses are controlled by the hypothalamic-pituitary adrenal axis 
(HPA), a key regulator of homeostasis, which responds to stress by triggering a series of 
endocrine changes resulting in the release of testosterone (T) and cortisol (C) (26). T is required 
for protein synthesis and glycogen replenishment, while C inhibits protein synthesis and can 
lead immunosuppression (31). Thus, the testosterone-to-cortisol ratio (T:C) can be viewed as the 
balance between anabolic to catabolic processes (i.e., recovery status/adaptation status) (50, 55) 
and has been proposed to monitor internal TL, fatigue, training stress, and adaptation (20, 33). 
A decrease in the T:C ratio ≥ 30% has been related to incomplete recovery from training (3). The 
T:C ratio is influenced by training volume (35, 50) and intensity (34, 36), often decreasing with 
fatigue (54). Training programs that have modulated training based on changes in the T:C ratio 
have shown enhanced performance outcomes in both individual (e.g., sprinting, throwing) and 
team sports (e.g., soccer) (23, 51). Thus, the T:C ratio may provide additional insight in both 
acute & chronic TL-induced stress. Despite its utility, regular assessment of T:C ratio is often 
infeasible in practical settings as it requires invasive serum or saliva collection and analysis (53). 
 
A promising non-invasive tool, heart rate variability (HRV), monitors internal TL and 
adaptation via the ANS and provides valuable insight into fatigue monitoring (1, 32, 42). HRV 
is estimated by measuring the time intervals between successive heartbeats, where an increase 
or decrease in these intervals reflects cardiac parasympathetic activity (32). Previous studies 
demonstrate that HRV is sensitive to individual variation in adaptation, fatigue, and overload 
during exercise training programs (13, 14, 42). Current assumptions are that training 
maladaptation is associated with reductions in cardiac parasympathetic activity and a decrease 
in HRV (42). Conversely, improved fitness is associated with increased cardiac parasympathetic 
activity and HRV (42). Unlike the T:C ratio, HRV appears to provide an easily assessed objective 
measure for evaluating fatigue when manipulating training prescriptions (28, 42). 
 
As the ANS and HPA work in tandem to respond to disrupted homeostatic processes, 
measuring stress responses from exercise training via the highly coordinated and interconnected 
ANS and HPA pathways (45, 48). Due to the complex integration of these systems, to date, no 
single definitive marker can accurately quantify the fitness and fatigue responses to training (4, 
6). Currently, the relationship between the ANS and hormonal balance throughout a 
multimodality exercise program such as high-intensity functional training (HIFT) is not well 
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understood (11). It has yet to be demonstrated if HRV and T:C ratio can identify fatigue in 
parallel with one another during HIFT. Therefore, the purposes of this study was to determine 
the relationship between daily resting HRV and pre-exercise T:C ratio and evaluate the clinical 
utility (i.e., diagnostic validity and reliability) of daily HRV assessment in classifying atypical 
T:C ratio changes throughout a nine-week HIFT intervention. It was hypothesized that HRV 
and T:C ratio would have a significant positive relationship and the daily HRV would be a valid 





Eight recreationally active men and women ages 18-35 were recruited for participation in the 
present study. All participants were currently regularly exercising, but not pursuing any specific 
health or fitness goal (e.g., weight loss or competition preparation) for at least six months prior 
to study commencement. All participants had previous experience with aerobic (9.1 ± 3.4 years) 
and resistance training (5.9 ± 3.4 years). All participants were considered a novice in regard to 
their experience with HIFT. Participant demographic characteristics are presented in Table 1. 
All participants were free of any physical or health limitations that might indicate a 
contraindication for vigorous exercise as determined by a medical history questionnaire and 
physical activity readiness questionnaire (PAR-Q) (52). Additionally, no participants reported 
taking any medications or having any physical conditions that could influence HRV. This 
investigation was approved by the University’s Institutional Review Board (#9131) and all 
participants provided written informed consent prior to study commencement. This research 
was carried out fully in accordance with the ethical standards of the International Journal of 
Exercise Science (38). 
 
Table 1. Participant characteristics. 
 Men (n = 4) Women (n = 4) 
Age 24.25 ±1.75 26.00 ±3.60 
Weight (kg) 79.68 ±11.66 73.4 ±8.42 
Height (cm) 181.25 ±3.86 164.25 ±3.30 
rHR 61.29 ±7.75 68.05 ± 6.30 
LnRMSSD 8.67 ±0.63 8.86 ±1.50 
T (nmol/L) 1.06 ±0.42 0.51 ±0.23 
C (nmol/L) 10.55 ±6.62 9.77 ±7.32 
T:C ratio (nmol/L) 0.14 ±0.12 0.08 ±0.08 
LnT:C -2.23 ±0.74 -2.75 ±0.74 




This study was a secondary analysis of a subset of participants from a larger study (8). 
Participants completed baseline demographic information and fitness testing prior to the start 
of a HIFT intervention. Following 14 days of baseline HRV assessments, participants were 
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randomized to either the treatment or control condition. Participants began the 60-minute 
exercise intervention sessions for five consecutive days (Monday-Friday) with two days of 
recovery (Saturday & Sunday). Two three-week training periods were interspersed between pre, 
mid and post-performance evaluation weeks, for a total of nine weeks (9). Full description of 
study intervention is provided in appendix table A1. Participants within the control condition 
completed all training sessions as prescribed. For participants within the treatment condition, 
training volume and intensity were manipulated based on potential meaningful shifts (SWC) in 
resting HRV as previously established (27, 28, 42). A participant HRV falling outside their SWC1 
reduced their work volume and external load (i.e., absolute weight used) by 25%. A participant 
HRV falling outside their SWC2 completed an active recovery session (e.g., walking and light 
stretching) for 20 minutes (9). Participant condition was balanced so that two males and two 
females were within each condition. Three training times were offered each day to accommodate 
participant schedules, and participants were asked to attend the same training time throughout 
the intervention. Throughout the intervention all participants completed daily resting HRV 
measurements and provided weekly pre-exercise saliva samples each Friday. 
 
Heart rate variability (HRV): Daily HRV measurements were taken via a commercially available 
smartphone application for both iOS and Android software HRV4Training (Amsterdam, 
Netherlands; seehttp://www.hrv4training.com/). The software utilized 
photoplethysmography to determine variability in R-R intervals from continuous heart rate data 
(43). In order to maintain HRV reliability, participants were instructed to, upon waking, empty 
their urinary bladder and return to a supine position before initiating the reading. Participant 
HRV was assessed in the supine position for one minute with the index finger covering the 
smartphone camera and the respiration rate set at 15 breaths per minute (10, 43). The 
methodology used for signal filtering, processing, interpolation, artifact correction, and R-R 
peak detection are detailed in the original reference for the applications development (43). HRV 
was collected for two weeks prior to the start of any testing protocol in order to establish a 
baseline. For day-to-day monitoring of individual recovery status (i.e., sympathovagal balance),  
the root mean squared of successive differences (RMSSD) of R-R intervals  was used as it appears 
to be less influenced by breathing rate and could be assessed validly in only one minute (10, 12, 
15, 42, 49). Due to the lack of normality, RMSSD was transformed using the natural logarithm 
(LnRMSSD), it was then multiplied by two so that LnRMSSD (HRVdaily) could be viewed on a 
scale of approximately six to ten for interpretation purposes and reflect application readout (57). 
A meaningful change in LnRMSSD was determined though smallest worthwhile change (SWC) 
in participants’ seven-day rolling average. The SWC was set as ± 0.5 standard deviations from 
an individual’s rolling seven-day LnRMSSD (27, 28, 41). Participants continued to measure their 
HRVdaily for the duration of the study following previously established protocols (9). 
Participants were asked to complete a total of 75 HRVdaily readings throughout this 
investigation, the cohort averaged a 93.3% adherence to the HRVdaily readings. 
 
Saliva Collection and Analysis: Participants provided saliva samples 15 minutes prior to their 
training sessions each Friday. Approximately 2 mL of saliva was collected via an oral swab 
(Salimetrics LLC, State College, PA, USA) and stored in a swab storage tube at -20°C until assay. 
A total of 70 samples were collected across the eight participants; one sample was lost due to 
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insufficient saliva collection. Participants provided their pre-exercise saliva sample within 5 
minutes of starting the standardized 10-minute warm-up. Concentrations of testosterone and 
cortisol were analyzed via a commercially available, enzyme-linked immunosorbent assay 
(ELISA) (Salimetrics LLC, State College, PA, USA), following the manufacturer’s guidelines. All 
samples were analyzed in duplicate with an average coefficient of variation (CV) of (4.766%) for 
testosterone and (5.285%) for cortisol. A 30% or greater decrease in T:C was deemed meaningful 
and was determined “at risk” (3). T:C values were compared on a weekly-to-week basis.  
 
The exercise intervention employed within this study followed a popular, community-based 
HIFT template (19). All training sessions were conducted as group exercise within the 
Functional Intensity Training Laboratory (FIT Lab) at Kansas State University. Specific details 
of the structure and components of each daily training session can be found in Table A1 within 
the previously published work by Crawford et al. (8). All training days included an instructor-
led warm-up; a brief movement preparation period, daily workout, and a cool-down lasting a 
total of approximately one hour in duration. Thirty training sessions were programmed for 
participants to complete, with an adherence rate of 80% required for data inclusion. 




Data were analyzed using the R statistical computing environment and language (v. 4.0; R Core 
Team, 2019) via the Jamovi graphical user interface (47). Data for HRV and T:C ratio were only 
analyzed if a daily matched pair existed; of the 72 total time points, five were missing a matched 
pair resulting in an analysis of 67 time points. The HRV and T:C ratio data were checked for 
normality (Shapiro-Wilk test). The T:C ratio was transformed using the natural log method 
(lnTC) prior to statistical analysis due to excessive skewness (2.27 ± 0.28) of these data (35). 
Relationships between HRV and salivary hormone data were assessed using linear mixed-
effects models via the GAMLj: General analyses for linear models module (18). Potential fixed 
effects covariates (sex and treatment group) in addition to random effects of time and the 
individual participant were explored. A model comparison approach was employed using the 
Akaike Information Criterion (AIC) goodness-of-fit metric to identify an alternative model that 
best explained the data for each relationship of interest (25). Missing data were treated using 
pairwise (i.e., available case) analyses and the resulting number of observations for each specific 
analysis is reported in the results section. An alpha level of 0.05 was used for all statistical 
inferences. Post hoc assessments were adjusted using the Bonferroni correction. A 2x2 table was 
constructed to allow the development of estimates for diagnostic validity (e.g., sensitivity and 
specificity) and reliability (e.g., positive and negative predictive value) of HRVdaily for 
detecting atypical changes (i.e., >30%) T:C ratio concentration (46). A posthoc power analysis 
conducted using G*Power 3.1 (Universität Kiel, Germany) determined that with 67 collected 
samples we achieved 93% statistical power for testing the relationship between resting heart rate 
and HRV, 80% statistical power for HRV and T:C ratio, and 98% statistical power for HRV, T 
and C relationships. 
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A statistically significant negative relationship was observed between HRVdaily and the T:C 
ratio (p < 0.05, R2 = -.315) (Figure 1B). The model which best explained the data resulted in AIC 
= 130.247 with factors HRVdaily (β = -0.218, 95%CI = -0.391, -0.044, t = -2.46, p < 0.05), Sex (β = 
0.450, 95%CI = -0.214, 1.114, t = 1.113, p = 0.242), and Group (β = -0.394, 95%CI = -1.089, 0.302, t 
= -1.11, p = 0.311). A significant main effect for sex (mean difference = -7.18, 95%CI = 2.2, 11.9, t 
= 2.88, p < 0.05) was observed in the rHR and HRVdaily relationship (R2 = .248, t = 2.88, 
difference = 7.18, p < 0.05) (Figure 1A). There was no significant relationship found between C 
and HRVdaily ( R2 = .249, t = -1.76, difference = -5.29, p = 0.167) (Figure 1C), and neither sex nor 
group were significant factors. A significant main effect for sex (mean difference = -6.82, 95%CI 
= .72, 1.07, t = -6.82, p < 0.05 ) was observed for the T and HRVdaily relationship (R2= .42, t = -
0.56, p < 0.05) (Figure 1D). 
 
 
Figure 1. Regression plots – A) rHR and HRVdaily, B) T:C and HRVdaily, C) C and HRVdaily and D) T and 
HRVdaily. HRVdaily – log of root mean squared of successive differences. 
 
All raw data and summary statistics are reported in Table 2. Within-participants the HRVdaily 
and T:C ratio relationships varied from weak to strong (R2 = - 0.101 to 0.665, p = 0.103 to 0.829). 
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Table 2. Individual participant data. 
Participant 1 (woman)- control TP 1 TP 2 TP3 TP 4 TP 5 TP 6 TP 7 TP 8 TP 9 
LnRMSSD 6.54 7.95 7.90 - 8.14 8.87 8.21 6.83 7.32 
Testosterone (nmol/L) 0.49 0.54 0.47 - 0.57 0.42 0.34 1.24 0.53 
Cortisol (nmol/L) 11.59 8.43 9.04 - 8.28 11.20 13.97 6.36 13.24 
T:C ratio 0.042 0.064 0.052 - 0.069 0.038 0.024 0.195 0.040 
Participant 2 (woman)- control TP 1 TP 2 TP3 TP 4 TP 5 TP 6 TP 7 TP 8 TP 9 
LnRMSSD 5.26 8.52 7.12 7.82 8.78 7.64 8.08 7.24 7.80 
Testosterone (nmol/L) 0.30 0.24 0.49 0.48 0.59 0.24 0.33 0.29 0.48 
Cortisol (nmol/L) 2.17 1.33 1.21 1.90 7.41 1.61 3.32 1.95 0.88 
T:C ratio 0.138 0.180 0.405 0.253 0.080 0.149 0.099 0.149 0.545 
Participant 3 (man)- control TP 1 TP 2 TP3 TP 4 TP 5 TP 6 TP 7 TP 8 TP 9 
LnRMSSD 7.48 8.28 9.07 8.30 8.57 8.80 8.49 8.79 8.36 
Testosterone (nmol/L) 0.99 0.71 0.85 1.42 1.54 0.98 1.24 0.47 1.16 
Cortisol (nmol/L) 6.76 2.62 1.48 3.53 12.07 4.15 6.58 3.32 2.60 
T:C ratio 0.146 0.271 0.574 0.402 0.128 0.236 0.188 0.142 0.446 
Participant 4 (man)-control TP 1 TP 2 TP3 TP 4 TP 5 TP 6 TP 7 TP 8 TP 9 
LnRMSSD 7.43 9.45 8.86 9.11 9.32 8.14 8.93 9.16 - 
Testosterone (nmol/L) 0.43 0.53 0.93 1.36 0.84 - 1.01 1.33 1.09 
Cortisol (nmol/L) 5.13 12.81 15.62 9.87 6.66 - 10.76 16.09 4.98 
T:C ratio 0.084 0.041 0.060 0.138 0.126 - 0.094 0.083 0.219 
Participant 5 (woman)- treatment TP 1 TP 2 TP3 TP 4 TP 5 TP 6 TP 7 TP 8 TP 9 
LnRMSSD 9.74 10.79 11.39 9.98 9.43 10.93 11.09 9.86 10.31 
Testosterone (nmol/L) 0.41 0.74 0.63 0.57 1.01 0.62 0.52 0.60 0.66 
Cortisol (nmol/L) 2.36 14.96 24.62 18.64 29.82 23.02 13.83 14.55 19.90 
T:C ratio 0.174 0.049 0.026 0.031 0.034 0.027 0.038 0.041 0.033 
Participant 6 (woman)- treatment TP 1 TP 2 TP3 TP 4 TP 5 TP 6 TP 7 TP 8 TP 9 
LnRMSSD 11.24 8.69 11.35 8.99 9.42 9.24 9.35 10.01 8.48 
Testosterone (nmol/L) 0.56 0.16 0.11 0.79 0.74 0.44 0.31 0.47 0.68 
Cortisol (nmol/L) 8.70 3.24 3.25 14.48 5.77 13.35 11.01 10.60 6.09 
T:C ratio 0.064 0.049 0.034 0.055 0.128 0.033 0.028 0.044 0.112 
Participant 7 (man)- treatment TP 1 TP 2 TP3 TP 4 TP 5 TP 6 TP 7 TP 8 TP 9 
LnRMSSD 8.65 9.76 9.48 8.61 9.72 9.18 9.00 8.83 - 
Testosterone (nmol/L) 0.71 0.71 0.93 1.76 2.06 1.17 1.26 1.32 0.69 
Cortisol (nmol/L) 5.82 20.03 26.47 17.10 9.39 8.97 14.31 14.58 4.70 
T:C ratio 0.122 0.035 0.035 0.103 0.219 0.130 0.088 0.091 0.147 
Participant 8 (man)- treatment TP 1 TP 2 TP3 TP 4 TP 5 TP 6 TP 7 TP 8 TP 9 
LnRMSSD 7.73 7.28 8.78 8.56 - 7.89 8.85 8.49 - 
Testosterone (nmol/L) 1.15 0.82 1.18 2.23 0.85 1.12 0.74 0.49 - 
Cortisol (nmol/L) 10.91 5.24 16.12 29.02 15.03 11.28 9.40 15.46 - 
T:C ratio 0.105 0.156 0.073 0.077 0.057 0.099 0.079 0.032 - 
Mean Data TP 1 TP 2 TP3 TP 4 TP 5 TP 6 TP 7 TP 8 TP 9 
LnRMSSD 8.01 8.84 9.24 8.77 9.05 8.84 9.00 8.65 8.46 
Testosterone (nmol/L) 0.63 0.55 0.69 1.23 1.03 0.71 0.72 0.78 0.76 
Cortisol (nmol/L) 6.68 8.58 12.2 13.5 11.8 10.5 10.4 10.4 7.48 
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Table 3 presents the diagnostic ability of HRVdaily for assessing unfavorable changes in the T:C 
ratio concentration. This method of HRVdaily assessment demonstrated strong sensitivity 
(95%), but poor specificity (5%) for detecting meaningful changes in T:C ratio. Further, 
HRVdaily showed an excessively high false-positive rate (95%) yet a preferable rate of false 
negatives (5%). HRVdaily also demonstrated a reasonable degree of negative diagnostic 
accuracy; successfully classifying 41 out of 58 (71%) “no risk”, less than a 30% change, T:C ratio 
days.  
Table 3. Clinical utility of HRV and T:C. 
 T:C Ratio (At Risk) T:C Ratio (No Risk) 
HRV (At Risk) 1 2 
HRV (No Risk) 17 41 
Measures of Validity and Reliability 
Diagnostic Accuracy  74% 
Sensitivity 95% 
Specificity 5% 
False Positive Rate 95% 
False Negative Rate 5% 
Positive Predictive Value 33% 




This study evaluated the relationship between HRVdaily and pre-exercise T:C ratio as well as 
the clinical utility of HRVdaily to detect changes in T:C ratio during a 9-week HIFT intervention. 
Our results do not fully support our primary hypothesis that HRVdaily and T:C ratio will 
respond in parallel; however, they do reaffirm the relationship between the ANS and HPA axis 
in response to physiological stress. This was demonstrated by elevated parasympathetic outflow 
resulting in an increase in LnRMSSD while the stimulated HPA axis increased cortisol secretion. 
However, the association between the ANS and HPA axis has high individual variability with 
men displaying a better HRVdaily and T relationship. Further, in support of our secondary 
hypothesis, we demonstrate for the first time that a commercially available HRV monitoring 
application could be used as a proxy measure to evaluate clinically meaningful fluctuations in 
T:C ratio throughout a high-intensity exercise intervention, particularly for men. 
 
We found that the ANS regulated changes in HRVdaily were negatively associated with the T:C 
ratio throughout 9-weeks of HIFT. Previous work by Huovinen et al. revealed a significant 
positive association between change in HRV, using standard deviation of normal to normal, and 
T:C ratio (24). The difference in findings may, in part, be due to the inability of Huovinen et al. 
to collect baseline hormone values resulting in the authors being unable to report the 
relationship on a single day (24). Despite Houvinen et al  demonstrating that improvements in 
HRV over time may occur with a greater T:C ratio, the single-day relationship is still unclear 
(24).  
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Our findings differ from previous research due to increased cortisol levels displayed by our 
participants. This is due in part to the applied stressor. Huovinen et al.’s participants were 
primarily under psychological strain, whereas our subjects completed regular bouts of HIFT 
that placed them under physiological strain (24). Previously, HIFT has been shown to produce 
a physiological overload that increases C levels and significantly reduces the T:C ratio (33). The 
physiological overload is result of the high training volume, short rest intervals and varied 
exercise selection design of HIFT. 
 
The observed positive relationship between C and HRVdaily also is in contrast to findings of 
Kuorelahti  who studied junior endurance athletes (30). The elevated cortisol levels we found 
may in part be due to the lack of HIFT experience within our participants. In contrast, Poderoso 
et al  showed decreasing cortisol levels in experienced HIFT participants over a six month period 
(44). Additionally, hormone samples were collected within 15-minutes prior to the start of 
training therefore it could be speculated that the increase in cortisol may have been due to 
anticipatory response to enable an improved performance (39, 40). 
 
Finally, our observed difference in HRV response may be the result of the specific training 
modality. Kliszczewicz et al. demonstrated that despite an acute HRV depression following a 
bout of HIFT, resting HRV values were not altered (29). It is possible that the ANS stress from 
HIFT is not sufficient to cause long term disruptions in HRV. Our results demonstrate that 
during 9-weeks of HIFT the activity of the ANS and HPA-axis were not matched across all 
individuals. The previously demonstrated positive relationship between HRV and T:C ratio 
may not hold true across all exercise training programs (30). 
 
We initially hypothesized there would be a significant relationship between HRV and T:C ratio. 
If true, this relationship would allow for daily measurement of HRV to serve as a non-invasive 
proxy for hormonal changes throughout an exercise intervention. As with all diagnostic 
assessments, we hoped HRVdaily would demonstrate a high degree of both sensitivity (i.e., an 
ability to rule-out meaningful change in T:C ratio) and specificity (i.e., an ability to rule-in 
meaningful change in T:C ratio). However, as is common with clinical tests, we were confronted 
with limitations of HRVdaily for monitoring fluctuations in T:C ratio. In particular, we found a 
lack of specificity (i.e., 5%) in HRVdaily accurately identifying negative changes in T:C ratio. 
That is, using resting HRV status missed 95% of the actual “at risk” T:C ratios. However, 
HRVdaily did demonstrate a high degree (i.e., 95%) of diagnostic sensitivity. Meaning, that if an 
individual’s resting HRV status indicated “no risk” there was a high likelihood that same 
person’s T:C ratio also indicated “no risk.” We argue that this finding highlights partial efficacy 
of HRVdaily to be utilized when a practitioner desires to monitor the hormonal status of his or 
her athletes in response to a training intervention.  
 
While a test that can both identify “at risk” and “no risk” would be preferred, tests that are good 
at one or the other still have clinical utility. For example, using HRVdaily, a person can 
reasonably infer that when the application indicates they are not at risk they are, in fact, not at 
risk for maladaptation on that particular day. However, if HRVdaily indicates they are at risk, 
the person might want to employ a secondary assessment that is more specific to help confirm 
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a meaningful change in T:C ratio. For the recreational athlete, the use of HRVdaily might be able 
to serve as the sole monitoring strategy of recovery status. As these individuals are typically not 
concerned with optimal performance and/or adaptation, the consequences of missing a 
potential training day due to a false-positive “at risk” classification are almost non-existent. 
Conversely, in high performance environments, a false-positive “at risk” HRVdaily 
classification would result in an athlete missing a training day and potentially produce 
suboptimal performance and/or adaptation.  
 
The present study is not without limitations. Throughout the investigation, we asked 
participants to not engage in any additional exercise outside of the intervention and we were 
not able to prevent or record additional activities that could have influenced measured variables 
(i.e., HRV and T:C ratio). Additionally, sleep quality and duration were not recorded and 
participant nutrition was not controlled nor standardized, all of which could affect T:C ratio and 
HRV responses. Furthermore, there is the potential that the use of an orthostatic assessment of 
HRV could have altered our findings as the positive relationship reported by Huovinen et al. 
was present during the standing portion of an orthostatic test (24). Strengths of this investigation 
included a high (≥80%) adherence rate to training and HRVdaily recordings. Additionally, no 
participants reported injuries. 
 
Future investigations should attempt to quantify individual and weekly training in order to 
account for HPA-axis and ANS changes influenced by exercise intensity and volume. Individual 
T:C ratio should be recorded daily in order to determine if fluctuations in the ANS and HPA-
axis are better related opposed to the summative response to a week of training. As our 
participants were novices with HIFT, future examinations should determine if these findings 
are consistent with more experienced participants. As more experienced individuals are 
typically the ones looking for advanced monitoring strategies to optimize training responses, 
future results may provide more practical application to this group. 
 
The present study demonstrates an association between the ANS and the HPA axis during 9-
weeks of HIFT. Additionally, we demonstrated that HRVdaily is sensitive enough to accurately 
classify 95% of positive T:C ratios. While these findings indicate HRVdaily may be a useful tool 
for recreational athletes to monitor recovery status, in more high-performance settings, a more 
specific secondary test may be needed to ensure valuable training time is not lost due to missing 
that the athlete was actually “at risk”. These observations further emphasize the potential of 
HRV for the guidance of training, however, as hormonal responses to training are highly 
individual the creation of individual ANS and hormonal profiles would increase the accuracy 
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